Gene-expression profiling and not immunophenotypic algorithms predicts prognosis in patients with diffuse large B-cell lymphoma treated with immunochemotherapy
Gonzalo Gutiérrez, Teresa M. Cardesa‐Salzmann, Fina Climent et al. · Blood · 2011
Diffuse large B-cell lymphomas (DLBCLs) can be divided into germinal-center B cell-like (GCB) and activated-B cell-like (ABC) subtypes by gene-expression profiling (GEP), with the latter showing a poorer outcome. Although this classification can be mimicked by different immunostaining algorithms, their reliability is the object of controversy. We constructed tissue microarrays with samples of 157 DLBCL patients homogeneously treated with immunochemotherapy to apply the following algorithms: Colomo (MUM1/IRF4, CD10, and BCL6 antigens), Hans (CD10, BCL6, and MUM1/IRF4), Muris (CD10 and MUM1/IRF4 plus BCL2), Choi (GCET1, MUM1/IRF4, CD10, FOXP1, and BCL6), and Tally (CD10, GCET1, MUM1/IRF4, FOXP1, and LMO2). GEP information was available in 62 cases. The proportion of misclassified cases by immunohistochemistry compared with GEP was higher when defining the GCB subset: 41%, 48%, 30%, 60%, and 40% for Colomo, Hans, Muris, Choi, and Tally, respectively. Whereas the GEP groups showed significantly different 5-year progression-free survival (76% vs 31% for GCB and activated DLBCL) and overall survival (80% vs 45%), none of the immunostaining algorithms was able to retain the prognostic impact of the groups (GCB vs non-GCB). In conclusion, stratification based on immunostaining algorithms should be used with caution in guiding therapy, even in clinical trials.
Cited by 321 works. doi:10.1182/blood-2010-12-322362 Open-access PDF
Authors
- Gonzalo Gutiérrez
- Teresa M. Cardesa‐Salzmann
- Fina Climent
- Eva M. González-Barca
- Santiago Mercadal
- José Luís Mate
- Juan‐Manuel Sancho
- Leonor Arenillas
- Sergi Serrano
- Lourdes Escoda
- Salomé Martínez
- Alexandra Valera
- Antonio Martı́nez
- Pedro Jares
- Magdalena Pinyol
- Adriana García‐Herrera
- Alejandra Martínez‐Trillos
- Eva Giné
- Neus Villamor
- Elı́as Campo
References
- Nonparametric Estimation from Incomplete Observations
- Nonparametric Estimation from Incomplete Observations
- Regression Models and Life-Tables
- Regression Models and Life-Tables
- Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
- WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues
- Conservatism of the approximation sigma (O-E)2-E in the logrank test for survival data or tumor incidence data.
- CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma
- 352. Note: Conservatism of the Approximation Σ(O - E) 2 /E in the Logrank Test for Survival Data or Tumor Incidence Data
- The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma